Clinical Trial: 21194

Trial Status: Open
Disease Type: Colorectal
Trial ID 21194
Sponsor ID Codebreak 101 (Subprotocol M)

A Phase 1b Study Evaluating the Safety, Tolerability, and Efficacy of Sotorasib in Combination with MVASI and FOLFIRI and in Combination with MVASI and FOLFOX in Subjects with Advanced Colorectal Cancer with KRAS G12C Mutation

1 Location

Locations

Fairfax Office

Learn More About This Trial

Other Relevant Trials
Trial ID GS-US-587-6156
Sponsor ID Gilead Sciences, Inc

A Phase 2, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Bevacizumab and FOLFIRI Versus Bevacizumab and FOLFIRI in Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (CRC)

Principal Investigator
Keeran R. Sampat, MD
3 Locations
Trial ID 20341
Sponsor ID BESPOKE

BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer (20-041-NCP)

Principal Investigator
Keeran R. Sampat, MD
3 Locations